Allow quicker access to drug therapy for spinal muscular atrophy, Health Ministry urged

KUALA LUMPUR: The Health Ministry has been urged to expedite access to a new drug therapy to treat those affected by spinal muscular atrophy (SMA), especially children, said founder of NGO WeCareJourney Yap Sook Yee.

Yee said that SMA is a progressive muscle wasting disease and one of the top genetic killer of babies below the age of two years old.